Locations:
Min Investment:
Max Investment:
Target Investment:
2002
Early-stage healthcare venture capital firm, with a focus on life science platforms, digital health, and animal health opportunities.
2014
Antibody therapeutics to treat cancer (Nasdaq: CMPX)
2021
Intratumoral immunotherapy.
2020
2020
Genetics-informed antibody therapies for I&I disorders.
2019
2019
Redefining the role of genomic laboratories in delivering better healthcare.
2020
2020
Platform company developing novel TCR therapies for cancer and autoimmune disease.
2018
2018
Peptide discovery platform company spun out from the University of Oxford
2018
2018
The future of clinical research.
2008
2008
Premier human antibody discovery and humanization.
2018
Transformative exosome therapeutics.